At Ernexa Therapeutics, we welcome strategic partnerships with researchers, biotech innovators, and industry leaders to co-develop or out-license our novel iMSC-based therapies. By working together, we can expand development pathways, accelerate clinical progress, and unlock the full potential of our engineered cell therapies.
We believe collaboration is key to delivering breakthrough treatments for patients with serious unmet needs. If you share our vision for innovation and impact, we invite you to connect and explore partnership opportunities with us.
And if you just want to connect or learn more about what we’re building, we’d love to hear from you.